MX9800981A - Promotor del gen de endoglina humana y su uso. - Google Patents

Promotor del gen de endoglina humana y su uso.

Info

Publication number
MX9800981A
MX9800981A MX9800981A MX9800981A MX9800981A MX 9800981 A MX9800981 A MX 9800981A MX 9800981 A MX9800981 A MX 9800981A MX 9800981 A MX9800981 A MX 9800981A MX 9800981 A MX9800981 A MX 9800981A
Authority
MX
Mexico
Prior art keywords
endogline
promoter
gene
human
pharmaceutical
Prior art date
Application number
MX9800981A
Other languages
English (en)
Other versions
MXPA98000981A (es
Inventor
Wolff Graulich
Dirk Nettelbeck
Hans-Harald Sedlacek
Rolf Mueller
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of MX9800981A publication Critical patent/MX9800981A/es
Publication of MXPA98000981A publication Critical patent/MXPA98000981A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)

Abstract

El presente invento se refiere al promotor del gen de endoglina humana o restos funcionales del mismo, y a su uso para preparar un fármaco.
MXPA/A/1998/000981A 1997-02-06 1998-02-04 Promotor del gen de endoglina humana y su uso MXPA98000981A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19704301A DE19704301C1 (de) 1997-02-06 1997-02-06 Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie
DE19704301.1 1997-02-06

Publications (2)

Publication Number Publication Date
MX9800981A true MX9800981A (es) 1998-08-30
MXPA98000981A MXPA98000981A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
HU9800247D0 (en) 1998-03-30
AU736724B2 (en) 2001-08-02
JPH11178A (ja) 1999-01-06
CZ33298A3 (cs) 1998-08-12
US6103527A (en) 2000-08-15
AR011110A1 (es) 2000-08-02
EP0857781A2 (de) 1998-08-12
EP0857781A3 (de) 2001-05-16
AU5293198A (en) 1998-08-13
CA2222981A1 (en) 1998-08-06
CN1196784C (zh) 2005-04-13
CZ289227B6 (cs) 2001-12-12
BR9800563A (pt) 1999-06-29
PL324688A1 (en) 1998-08-17
DE19704301C1 (de) 1998-03-26
CN1203948A (zh) 1999-01-06
KR19980071084A (ko) 1998-10-26
HUP9800247A3 (en) 2002-11-28
HUP9800247A2 (hu) 1998-10-28
RU2230115C2 (ru) 2004-06-10
TR199800168A2 (xx) 1998-08-21

Similar Documents

Publication Publication Date Title
HK1032759A1 (en) Apparatus for restoring the balance of the human body.
MY117805A (en) Resorcinol derivatives
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
HK1034523A1 (en) Hemiasterlin analogs
ZA983849B (en) Pharmaceutical compositions of tizoxanide and nitazoxanide.
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
ZA982568B (en) The specificity of gene expression.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
HUP9800574A3 (en) Promoter of the cdc 25b gene, its preparation and use
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
HK1025907A1 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide.
ZA982060B (en) Delivery of skin benefit agents via adhesive strips.
HUP9600517A3 (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or valemic colchicine and thiocolchine and analogues and derivatives and intermediates
AU6849198A (en) Neurotrypsin
MX9800981A (es) Promotor del gen de endoglina humana y su uso.
ZA969315B (en) Processes and intermediates for the preparation of ziprasidone.
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
AU6034298A (en) Two human homologues of galectin-5
ZA967281B (en) Polymorphs of the pro drug 6-N-(L-ALA-L-ALA)-trovafloxacin.
EP0880971A3 (en) Macrophage stimulating protein for the treatment of pathologies of the nervous system
AU7772698A (en) Use of indolamines as antithrombotic medicine
ZA986324B (en) Composition for the treatment of immunodeficiency disease
AU4448497A (en) Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees